Boll, D.

patient cancer survival adjuvant radiotherapy carcinoma endometrial co-morbidity radiotherapy tumor study incidence netherland stage treatment diagnosis adjuvant sarcoma malignancy table corpus period group corpus uteri malignancies uteri serou endometrial cancer hysterectomy guideline carcinosarcoma stage i ec diabetes registry adenocarcinoma netherlands cancer registry disease 60 years serous carcinoma grade condition number breast cancer co-morbid conditions dutch guidelines 0.1 gynecol oncol journal factor gynecol oncol breast 5- year corpus uteri 2012 igcs 0.0 population uterine classification tamoxifen stromal analysis 1989 y 1993 adenosquamou epithelial endometrial carcinomas risk factors women differentiation serous adenocarcinoma mullerian department co-morbid change dutch result epithelial study period 0.3 age-standardized incidence trial histopathological diagnosis cell carcinoma